↓ Skip to main content

The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro

Overview of attention for article published in Antiviral Research, April 2020
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • One of the highest-scoring outputs from this source (#1 of 2,902)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (97th percentile)

Citations

dimensions_citation
1650 Dimensions

Readers on

mendeley
3274 Mendeley
Title
The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro
Published in
Antiviral Research, April 2020
DOI 10.1016/j.antiviral.2020.104787
Pubmed ID
Authors

Leon Caly, Julian D. Druce, Mike G. Catton, David A. Jans, Kylie M. Wagstaff

X Demographics

X Demographics

The data shown below were collected from the profiles of 25,041 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 3,274 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 3274 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 432 13%
Researcher 359 11%
Student > Master 318 10%
Student > Ph. D. Student 267 8%
Other 200 6%
Other 708 22%
Unknown 990 30%
Readers by discipline Count As %
Medicine and Dentistry 593 18%
Biochemistry, Genetics and Molecular Biology 317 10%
Pharmacology, Toxicology and Pharmaceutical Science 292 9%
Agricultural and Biological Sciences 180 5%
Chemistry 144 4%
Other 608 19%
Unknown 1140 35%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 21998. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 June 2024.
All research outputs
#23
of 26,168,182 outputs
Outputs from Antiviral Research
#1
of 2,902 outputs
Outputs of similar age
#6
of 401,795 outputs
Outputs of similar age from Antiviral Research
#1
of 41 outputs
Altmetric has tracked 26,168,182 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,902 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 18.2. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 401,795 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 41 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.